NCT05547594

Brief Summary

Surgical prehabilitation refers to pre-operative interventions aimed at increasing patients' physiological reserve so that they can better cope with the stress of surgery, avoid post-operative complications and have a faster recovery after surgery. Multimodal prehabilitation combines different aspects related to a healthy lifestyle including but not limited to; physical activity, nutritional education, anxiety coping strategies, alcohol moderation and smoking cessation. Although these aspects are well known, having a cancer diagnosis and the likelihood of an incoming operation during the weeks after diagnosis, place patients in a situation where they may be more receptive to adopting lifestyle changes aimed at promoting health. Such changes could be incorporated, not just in the short-term in preparation for surgery, but also in the medium- and long-term, improving patients' wellbeing and potentially reducing the risk of cancer reoccurrence and other diseases. Although the benefits of prehabilitation before surgery are understood, the effects it may have in non-insulin-dependent Type 2 diabetes patients are unknown. This project aims to: (i) Analyse the effects of a multimodal prehabilitation programme vs. the current National Health Service (NHS) standard approach, on physical performance in cancer patients with non-insulin-dependent Type 2 diabetes prior to surgery. (ii) Explore the impact of the programme on body composition and metabolic markers. (iii) Analyse the programme adherence, markers of well-being and quality of life during a post-surgery period of up to 12 months as well as its effects on clinical outcomes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 21, 2022

Completed
1.3 years until next milestone

Study Start

First participant enrolled

January 18, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

May 28, 2024

Status Verified

May 1, 2024

Enrollment Period

1 year

First QC Date

September 12, 2022

Last Update Submit

May 24, 2024

Conditions

Keywords

cancerType 2 diabetessurgeryprehabilitationrecoveryexercisenutritionproteinanxietyquality of lifephysical performance

Outcome Measures

Primary Outcomes (1)

  • Changes in Short Physical Performance Battery (SPPB) at different time points from baseline to 1 year after surgery

    Group of measures that combines the results of the gait speed, chair stand and balance tests, with scores ranging from 0 (worst performance) to 12 (best performance).

    upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery

Secondary Outcomes (6)

  • Changes in fasting glucose at different time points from baseline to 1 year after surgery

    upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery

  • Changes in fasting insulin at different time points from baseline to 1 year after surgery

    upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery

  • Changes in BMI at different time points from baseline to 1 year after surgery

    upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery

  • Changes in waist circumference at different time points from baseline to 1 year after surgery

    upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery

  • Changes in hip circumference at different time points from baseline to 1 year after surgery

    upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery

  • +1 more secondary outcomes

Other Outcomes (3)

  • Hospital length of stay

    8 weeks after surgery

  • 90-day readmission

    90 days after surgery

  • Postsurgical complications

    6 months after surgery

Study Arms (2)

Prehabilitation

EXPERIMENTAL

Arm undergoing multimodal prehabilitation (physical activity, nutritional education and anxiety management) during the weeks leading up to surgery

Behavioral: Multimodal surgical prehabilitation

Standard of care

NO INTERVENTION

Arm receiving standard of care (no prehabilitation)

Interventions

Participants will be encouraged to engage in regular physical activity (endurance and resistance exercise), eat healthily and undergo cognitive behavioural therapy (the latter only if required) during the weeks prior to surgery.

Prehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Capacity to give consent
  • Newly diagnosed with cancer
  • Non-insulin-dependent Type 2 diabetes
  • Awaiting surgery for cancer

You may not qualify if:

  • Medical contraindication to engage in physical activity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

School of Human Sciences, University of Greenwich, Avery Hill Campus, Sparrows Farm (Office SF112B)

Eltham, England, SE9 2BT, United Kingdom

NOT YET RECRUITING

King's College Hospital

London, United Kingdom

RECRUITING

Related Publications (1)

  • Wu F, Rotimi O, Laza-Cagigas R, Rampal T. The Feasibility and Effects of a Telehealth-Delivered Home-Based Prehabilitation Program for Cancer Patients during the Pandemic. Curr Oncol. 2021 Jun 17;28(3):2248-2259. doi: 10.3390/curroncol28030207.

MeSH Terms

Conditions

NeoplasmsDiabetes Mellitus, Type 2Motor ActivityAnxiety Disorders

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehaviorMental Disorders

Study Officials

  • Fernando Naclerio, PhD

    University of Greenwich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Roberto Laza-Cagigas, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor in Strength Training and Sports Nutrition

Study Record Dates

First Submitted

September 12, 2022

First Posted

September 21, 2022

Study Start

January 18, 2024

Primary Completion

January 30, 2025

Study Completion

April 30, 2025

Last Updated

May 28, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations